Skip to main content
. Author manuscript; available in PMC: 2012 Jun 25.
Published in final edited form as: Cardiovasc Revasc Med. 2010 Oct 20;12(2):111–122. doi: 10.1016/j.carrev.2010.05.003

Figure 2.

Figure 2

Long and short axis views of DE-MR images illustrate the hyperenhanced infarct at 5 weeks after infarction of two representative animals (top block). The bottom block shows the effects of pCK-LacZ (top row) and pCK-HGF genes (bottom row) on infarct transmurality (arrow) and size 5 weeks after treatment. Histochemical TTC staining (right LV slices) confirms the smaller and non-transmural infarct (arrow) in the pCK-HGF treated animal compared with pCK-LacZ control animal.